| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/07/2009 | WO2009057702A1 Polymer for detection of target substance, and method for detection of target substance |
| 05/07/2009 | WO2009057695A1 Method for detection of adenoma or cancer by genetic analysis |
| 05/07/2009 | WO2009057664A1 Antibody and use thereof |
| 05/07/2009 | WO2009057640A1 Method for determination of inflammatory disease by using single nucleotide polymorphism in brca1-related protein (brap) gene |
| 05/07/2009 | WO2009057622A1 Method for production of human growth hormone improved in efficiency |
| 05/07/2009 | WO2009057533A1 Method for producing aminopeptidase |
| 05/07/2009 | WO2009057461A1 Therapeutic agent for diabetes |
| 05/07/2009 | WO2009057313A1 Method for induction of proliferation/differentiation of endothelial progenitor cell (epc) |
| 05/07/2009 | WO2009057294A1 Gene associated with liver cancer, and method for determination of the risk of acquiring liver cancer |
| 05/07/2009 | WO2009057230A1 Method for producing cytidine 5'-monophosphate |
| 05/07/2009 | WO2009057061A1 Transgenic plants and modulators for improved stress tolerance |
| 05/07/2009 | WO2009056984A1 Method of modifying a yeast cell for the production of ethanol |
| 05/07/2009 | WO2009056955A1 Amine-bearing phospholipids (abps), their synthesis and use |
| 05/07/2009 | WO2009056803A1 Methods and compositions |
| 05/07/2009 | WO2009056689A1 Use of a legume albumin, pa1a, as an insecticide |
| 05/07/2009 | WO2009056671A1 Method for inhibiting angiogenesis or for treatment of cancer |
| 05/07/2009 | WO2009056597A1 Insect inhibiting plant serpin mutants |
| 05/07/2009 | WO2009056584A1 Anticomplement polypeptides of ixodes ricinus |
| 05/07/2009 | WO2009056566A2 Plants having enhanced yield-related traits and a method for making the same |
| 05/07/2009 | WO2009056434A1 Combination products for treating cancer |
| 05/07/2009 | WO2009056419A1 Methods for producing a non human animal model for aortic aneurysm |
| 05/07/2009 | WO2009056330A1 Soluble truncated apom proteins and medical uses thereof |
| 05/07/2009 | WO2009056321A1 Controlled activation of non-ltr retrotransposons in mammals |
| 05/07/2009 | WO2009056257A1 Quadruple transgenic non-human animal |
| 05/07/2009 | WO2009056155A1 Method to produce modified plants with altered n-glycosylation pattern |
| 05/07/2009 | WO2009056116A1 Method for the promotion of angiogenesis, vascularization, or vascular repair or for the inhibition of tumor angiogenesis |
| 05/07/2009 | WO2009055936A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
| 05/07/2009 | WO2009055926A1 Method of determining risk for cancer |
| 05/07/2009 | WO2009055854A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | WO2009038707A9 Cancer-testis gene silencing agents and uses thereof |
| 05/07/2009 | WO2009037266A3 Method for detecting or quantifying a truncating mutation |
| 05/07/2009 | WO2009036385A3 Expression of nucleic acid sequences for production of biofuels and other products in algae and cyanobacteria |
| 05/07/2009 | WO2009036299A3 Compositions and methods for the identification of inhibitors of retroviral infection |
| 05/07/2009 | WO2009032781A3 Methods and compositions for universal size-specific polymerase chain reaction |
| 05/07/2009 | WO2009032172A3 Platinum compositions as treatment for oct-related cancers |
| 05/07/2009 | WO2009031835A3 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same |
| 05/07/2009 | WO2009029130A3 Raccoon poxvirus expressing genes of porcine virus |
| 05/07/2009 | WO2009027507A3 Aptamers which bind to a target molecule involved in haemostasis |
| 05/07/2009 | WO2009026445A3 Methods and compositions for post-transcriptional gene silencing |
| 05/07/2009 | WO2009023270A3 Compositions and methods for modifying properties of biologically active polypeptides |
| 05/07/2009 | WO2009020645A3 Matriptase protein and uses thereof |
| 05/07/2009 | WO2009018335A9 Targeting brain cells via ophtalmic delivery |
| 05/07/2009 | WO2009016208A3 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms |
| 05/07/2009 | WO2009012176A3 Methods and compositions for treating brain diseases |
| 05/07/2009 | WO2009007244A3 Replication deficient influenza virus for the expression of heterologous sequences |
| 05/07/2009 | WO2009003078A3 Temporal regulation of gene expression by micrornas |
| 05/07/2009 | WO2008149176A8 Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof |
| 05/07/2009 | WO2008137761A3 Rna interference mediated inhibition of cyclic nucleotide type 4 phosphodiesterase (pde4b) gene expression using short interfering nucleic acid (sina) |
| 05/07/2009 | WO2008132234A3 Rna antagonist compounds for the modulation of beta-catenin |
| 05/07/2009 | WO2008112972A3 Centromere sequences and minichromosomes |
| 05/07/2009 | WO2008112475A3 Protein sweetener |
| 05/07/2009 | WO2008109520A4 Nucleic acid compounds for inhibiting cxc gene expression and uses thereof |
| 05/07/2009 | WO2008098995A3 Genes involved in mitochondrial biogenesis |
| 05/07/2009 | WO2008073348A3 Microgravity bioreactor systems for production of bioactive compounds and biological macromolecules |
| 05/07/2009 | WO2008050329A3 Novel sirnas and methods of use thereof |
| 05/07/2009 | WO2008038272A3 Isolated polynucleotides, nucleic acid constructs, methods and kits for localization of rna and/or polypeptides within living cells |
| 05/07/2009 | WO2007136988A3 Compounds and methods for modulating expression of gccr |
| 05/07/2009 | WO2007134161A8 Compositions and methods for inhibiting expression of the pcsk9 gene |
| 05/07/2009 | WO2007106571A3 Methods of screening for and mapping phenotypic and genotypic variations in cells |
| 05/07/2009 | WO2007100357A3 Stem cell factor-like protein scfa1 and uses thereof |
| 05/07/2009 | WO2007059297A3 Multimeric biosensors and methods of using the same |
| 05/07/2009 | WO2007051063A3 Gpcr expressing cell lines and antibodies |
| 05/07/2009 | WO2007038548A3 Compositions and methods of using chondroitinase abci mutants |
| 05/07/2009 | WO2007027910A3 Peptide mimics of melanocyte stimulating hormone |
| 05/07/2009 | WO2007025181A3 Aureobasidin a synthetase |
| 05/07/2009 | WO2007014162A3 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 05/07/2009 | WO2006084342A3 Isolated nucleic acid molecules encoding plant transcription factors in the knox family |
| 05/07/2009 | WO2006073587A3 Hemipteran 5-hydroxytryptamine 7 serotonin receptor |
| 05/07/2009 | WO2006053313A3 Elaiophylin biosynthetic gene cluster |
| 05/07/2009 | WO2006052824A3 A mortierella alpina glycerol-3-phosphate o-acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/07/2009 | WO2006029398A3 All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use |
| 05/07/2009 | WO2006025060A3 Salt responsive genes useful for generating salt resistant transgenic plants |
| 05/07/2009 | WO2006017813A3 Methods and compositions for detecting steroids |
| 05/07/2009 | WO2005089386A3 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 05/07/2009 | US20090119805 Nuleic acid constructs and methods for producing altered seed oil compositions |
| 05/07/2009 | US20090119804 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt2 polypeptides and homologs thereof |
| 05/07/2009 | US20090119799 nucleic acid molecule encoding an isolated polypeptide having fungicidal activity against Colletotrichum, Diplodia, or Fusarium |
| 05/07/2009 | US20090119798 Barley Row Type Gene and Use Thereof |
| 05/07/2009 | US20090119797 Gro-1 herbicide resistance gene and methods for its use |
| 05/07/2009 | US20090119796 Modification of plant lignin content |
| 05/07/2009 | US20090119795 Delta-9-Elongases and their Use in Making Polyunsaturated Fatty Acids |
| 05/07/2009 | US20090119794 Methods and means for determining and conferring stress tolerance in plants |
| 05/07/2009 | US20090119787 Cell nuclear transfer |
| 05/07/2009 | US20090118486 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 05/07/2009 | US20090118483 Light-driven energy generation using proteorhodopsin |
| 05/07/2009 | US20090118481 High Affinity Nucleic Acid Ligands To Lectins |
| 05/07/2009 | US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins |
| 05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
| 05/07/2009 | US20090118371 Delta 6 Desaturase From Thraustochytrid and its Uses Thereof |
| 05/07/2009 | US20090118219 Flea gaba receptor subunit nucleic acid molecules |
| 05/07/2009 | US20090118217 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 05/07/2009 | US20090118216 Anaplastic lymphoma kinase (alk) as oncoantigen for lymphoma vaccination |
| 05/07/2009 | US20090118214 Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
| 05/07/2009 | US20090118213 Rna antagonist compounds for the inhibition of apo-b100 expression |
| 05/07/2009 | US20090118212 Methods for producing and using in vivo pseudotyped retroviruses |
| 05/07/2009 | US20090118210 Epididymal lipocalin gene and uses thereof |
| 05/07/2009 | US20090118208 Composition and methods of RNAI therapeutics for treatment of cancer and other neovascularization diseases |
| 05/07/2009 | US20090118207 Use of apoptosis-specific eIF-5A siRNA to down regulate expression of proinflammatory cytokines to treat sepsis |
| 05/07/2009 | US20090118206 Rna interference for the treatment of gain-of-function disorders |
| 05/07/2009 | US20090118205 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and uses Thereof in the Treatment of Cancer |